[HTML][HTML] Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials

F Coccolini, M Nardi, G Montori, M Ceresoli… - International Journal of …, 2018 - Elsevier
Introduction Even in after curative surgery and adequate linfoadenectomy the survival of
advanced gastric cancer (AGC) remains poor. At present some data have been published …

Perioperative chemo (radio) therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus

U Ronellenfitsch, M Schwarzbach… - Cochrane Database …, 2013 - cochranelibrary.com
Background The outcome of patients with locally advanced gastroesophageal
adenocarcinoma (adenocarcinoma of the esophagus, gastroesophageal (GE) junction, and …

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent …

AE Slagter, EPM Jansen, HWM van Laarhoven… - Bmc Cancer, 2018 - Springer
Background Although radical surgery remains the cornerstone of cure in resectable gastric
cancer, survival remains poor. Current evidence-based (neo) adjuvant strategies have …

German S3-guideline" Diagnosis and treatment of esophagogastric cancer"

M Moehler, SE Al-Batran, T Andus… - Zeitschrift fur …, 2011 - pubmed.ncbi.nlm.nih.gov
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"] [German S3-guideline
"Diagnosis and treatment of esophagogastric cancer"] Z Gastroenterol. 2011 Apr;49(4):461-531 …

[HTML][HTML] Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?

R Reddavid, S Sofia, P Chiaro, F Colli… - World journal of …, 2018 - ncbi.nlm.nih.gov
AIM To investigate the neoadjuvant chemotherapy (NAC) effect on the survival of patients
with proper stomach cancer submitted to D2 gastrectomy. METHODS We proceeded to a …

N eo FLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma …

C Schulz, F Kullmann, V Kunzmann… - … journal of cancer, 2015 - Wiley Online Library
Perioperative treatment is a standard of care in locally advanced gastroesophageal cancer
(GEC)(gastric adenocarcinoma and gastroesophageal junction (GEJ) adenocarcinoma) …

Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally …

S Lorenzen, C Pauligk, N Homann… - British journal of …, 2013 - nature.com
Background: The aim of this exploratory subgroup analysis of the fluorouracil, oxaliplatin,
docetaxel (FLOT) 65+ trial was to determine tolerability and feasibility of perioperative …

[HTML][HTML] Diagnosis and evaluation of gastric cancer by positron emission tomography

CX Wu, ZH Zhu - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Gastric cancer is the second leading cause of cancer mortality worldwide. The diagnosis of
gastric cancer has been significantly improved with the broad availability of gastrointestinal …

Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials

AM Xu, L Huang, W Liu, S Gao, WX Han, ZJ Wei - PLoS One, 2014 - journals.plos.org
Background The effect of neoadjuvant chemotherapy (NAC) on Gastric carcinoma (GC) has
been extensively studied, while its survival and surgical benefits remain controversial. This …

An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer

BH Xiong, Y Cheng, L Ma, CQ Zhang - Cancer investigation, 2014 - Taylor & Francis
Patients with locally advanced gastric cancer (AGC) have a poor outcome. We performed an
updated meta-analysis to assess the effect of neoadjuvant chemotherapy (NAC). By …